BRAFV600E Is A Negative Prognosticator In Pediatric Ganglioglioma | 16409
Journal of Clinical & Experimental Pathology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Gangliogliomas are typically low-grade neuroepithelial tumors seen in the pediatric and young adult populations.
Despite their often bland histologic appearance, these tumors can recur with varying frequency; however, little data
exist that adequately predict ganglioglioma recurrence in children. To identify potential histopathologic features predictive
of recurrence- free survival, a series of 53 pediatric gangliogliomas were evaluated. Fifteen patients (28%) exhibited
disease recurrence during the study period. BRAF
immunohistochemistry was performed on 47 tumor samples, and
histopathologic findings were analyzed against survival data. Histopathologic features associated with longer recurrence-
free survival included oligodendroglial morphology, tumor cell density, microvascular proliferation, and the presence of a
lymphoplasmacytic inflammatory infiltrate. Eighteen tumors (38.3%) exhibited positive BRAF
staining. Positive BRAF
staining was associated with shorter recurrence- free survival. The present study marks the largest pediatric cohort of World
Health Organization (WHO) grade I gangliogliomas with accompanying histopathologic and survival data. Collectively, the
combined use of histopathologic and molecular features to stratify grade I gangliogliomas into low and high risk groups
provides important information relevant to the management of children and young adults with these rare tumors.
Sonika Dahiya completed her medical schooling and Pathology residency in India followed by a research fellowship in Molecular Pathology (Massachusetts
General Hospital and Harvard Medical School), retraining in Pathology (New York University School of Medicine) and Neuropathology fellowship (Washington
University School of Medicine) in USA. She is currently an Assistant Professor in Department of Pathology & Immunology at Washington University School of
Medicine in St. Louis. Her research interest is investigation of prognostic and predictive markers in brain tumors.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals